The State of Immune Reactivity During the Treatment of Genital Herpes in Patients Who Have Undergone Covid-19

Guli A. Ismailova, Firuza B. Mirodilova, Nodira S. Saipova, Farkhod F. Hashimov, Gayratillo Sh. Tokhtaev, Azizbek F. Valijonov, Shirina A. Valijonova.

dc.contributor.author	Guli A. Ismailova, Firuza B. Mirodilova, Nodira S. Saipova, Farkhod F. Hashimov, Gayratillo Sh. Tokhtaev, Azizbek F. Valijonov, Shirina A. Valijonova.
dc.date.accessioned	2022-10-11T13:51:27Z
dc.date.available	2022-10-11T13:51:27Z
dc.date.issued	2022
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/3289
dc.description.abstract	Relapses of herpes simplex during the COVID-19 pandemic in patients with or without respiratory symptoms alarm us about the possibility of SARS-CoV-2 infection in these patients. Both the stress caused during the pandemic and the invasion of SARS-CoV-2 itself are generative elements of immunodeficiency in humans, a situation that can be used by the herpes virus to reactivate and infect the host .	en_US
dc.language.iso	en	en_US
dc.publisher	Other	en_US
dc.subject	SARS-CoV-2, Recurrent Genital Herpes, HSV-1, HSV-2.	en_US
dc.title	The State of Immune Reactivity During the Treatment of Genital Herpes in Patients Who Have Undergone Covid-19	en_US
dc.type	Article	en_US